STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Prieinama:

Sanofi-Aventis Australia Pty Ltd

INN (Tarptautinis Pavadinimas):

prochlorperazine mesilate

Vaisto forma:

Injection

Sudėtis:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Vartojimo būdas:

Intramuscular

Vienetai pakuotėje:

10 x 1 mL

Recepto tipas:

(S1) This Schedule is intentionally blank

Terapinės indikacijos:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Produkto santrauka:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Autorizacija statusas:

Licence status A

Leidimo data:

2007-07-16